jeudi 30 janvier 2020

Onco Actu du 30 janvier 2020


1. BIOLOGIE



Peripheral Blood From Patients with Metastatic Solid Tumors Is A Source of p53-reactive T cells [AACR]











3.1 PRÉVENTION - TABAC



Smoking Induces Mutations in Lung Tissue but Quitting Helps Replenish Healthy Cells [Genome Web]











Lungs damaged by smoking can 'magically' heal – study [The Guardian]











Never too late to quit: protective cells could cut risk of lung cancer for ex-smokers [Sanger Institute]










3.4 CHIMIOPRÉVENTION



Antibiotic therapy cuts stomach cancer rate by more than half in high-risk population [Reuters]











4.10 DÉP., DIAG. & PRONO. - POUMON



NELSON Trial Confirms Mortality Benefit of Lung Cancer Screening [ACS]











CT screening cuts lung cancer deaths in European men and women [Reuters]










4.9 DÉP., DIAG. & PRONO. - SEIN



Breast Cancer Risk Clues Found By Sequencing Cells From BRCA2 Germline Mutation Carriers [Genome Web]











5.17 TRAITEMENTS - RADIOTHÉRAPIE



Researchers capture first images of oxygen in cancer tumors during radiation therapy [Dartmouth]











5.2 PHARMA



Novartis rethinks CML strategy for next-gen allosteric drug due for a pivotal readout later this year [EndPoints]











5.2.4 PHARMA - LILLY



Racing Blueprint, Lilly drug gets priority review for RET hopeful [Fierce Biotech]











Lilly Receives FDA Priority Review for the Selpercatinib New Drug Application [Lilly]











5.3 TRAITEMENTS - FDA, EMA,...



Key principles for the use of electronic product information for EU medicines [EMA]











5.3.4 TRAITEMENTS - AMM (FDA, EMA,...)



European Commission expands use for Janssen’s Erleada [Pharma Times]











6.1 OBSERVATION



Global burden of cancer attributable to infections: the critical role of implementation science [The Lancet Global Health]










Cancer Related to Infections [ESMO]











6.10 POLITIQUES



On eve of Brexit, Britain faces critical test to defend drug trial crown [Reuters]